Literature DB >> 2512158

Bacteremia and fungemia in the immunocompromised patient.

T E Kiehn1.   

Abstract

Considerable changes have occurred during the 1980s in the clinical nature and diagnosis of bacteremia and fungemia in the immunocompromised patient. Cancer patients with prolonged neutropenia, many with indwelling catheters, and AIDS patients with both T-cell and B-cell deficiencies have changed the spectrum of organisms causing septicemia. There has been a shift to infection with gram-positive bacteria, including mycobacteria, and water-borne organisms, including Acinetobacter spp. and Pseudomonas spp. New blood culture systems, including a lysis-centrifugation system and radiometric methods utilizing resin broth media, remove antagonistic antimicrobial agents, and the lysis-centrifugation system routinely provides quantitation of organisms from the blood. Quantitation has been used to identify sources of infection, to differentiate contamination from true infection, and to monitor the course of antibiotic treatment.

Entities:  

Mesh:

Year:  1989        PMID: 2512158     DOI: 10.1007/bf02185856

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  35 in total

1.  Value of semiquantitative cultures of blood drawn through catheter hubs for estimating the risk of catheter tip colonization in cancer patients.

Authors:  A Andremont; R Paulet; G Nitenberg; C Hill
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

2.  Clinical comparison of lysis-centrifugation and radiometric resin systems for blood culture.

Authors:  P Brannon; T E Kiehn
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

3.  Routine use of BACTEC 16B bottles to remove antibacterial and antitumor agents from blood cultures of cancer patients.

Authors:  R L Hopfer; D G Moore; V Fainstein; S Watkins; M Wenglar
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

4.  Rapid identification using a specific DNA probe of Mycobacterium avium complex from patients with acquired immunodeficiency syndrome.

Authors:  T E Kiehn; F F Edwards
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

5.  Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics.

Authors:  T E Kiehn; F F Edwards; P Brannon; A Y Tsang; M Maio; J W Gold; E Whimbey; B Wong; J K McClatchy; D Armstrong
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

6.  Increasing incidence of Gram-positive sepsis in cancer patients.

Authors:  P A Pizzo; S Ladisch; R M Simon; F Gill; A S Levine
Journal:  Med Pediatr Oncol       Date:  1978

7.  Prospective study of infections in indwelling central venous catheters using quantitative blood cultures.

Authors:  D Benezra; T E Kiehn; J W Gold; A E Brown; A D Turnbull; D Armstrong
Journal:  Am J Med       Date:  1988-10       Impact factor: 4.965

8.  Bacteremia and fungemia in patients with the acquired immunodeficiency syndrome.

Authors:  E Whimbey; J W Gold; B Polsky; J Dryjanski; C Hawkins; A Blevins; P Brannon; T E Kiehn; A E Brown; D Armstrong
Journal:  Ann Intern Med       Date:  1986-04       Impact factor: 25.391

9.  Septicemia caused by the gram-negative bacterium CDC IV c-2 in an immunocompromised human.

Authors:  M Dan; S A Berger; D Aderka; Y Levo
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948

10.  Comparative recovery of bacteria and yeasts from lysis-centrifugation and a conventional blood culture system.

Authors:  T E Kiehn; B Wong; F F Edwards; D Armstrong
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

View more
  7 in total

1.  Detection of bacteria in blood by centrifugation and filtration.

Authors:  M Bernhardt; D R Pennell; L S Almer; R F Schell
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  Changes in the spectrum of organisms causing bacteremia and fungemia in immunocompromised patients due to venous access devices.

Authors:  T E Kiehn; D Armstrong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-12       Impact factor: 3.267

3.  Assessment of routine use of an anaerobic bottle in a three-component, high-volume blood culture system.

Authors:  W C Hellinger; J J Cawley; S Alvarez; S F Hogan; W S Harmesen; D M Ilstrup; F R Cockerill
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

4.  Quantitation of Candida CFU in initial positive blood cultures.

Authors:  Christopher D Pfeiffer; Gregory P Samsa; Wiley A Schell; L Barth Reller; John R Perfect; Barbara D Alexander
Journal:  J Clin Microbiol       Date:  2011-06-15       Impact factor: 5.948

Review 5.  Nonculture methods for diagnosis of disseminated candidiasis.

Authors:  E Reiss; C J Morrison
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

6.  Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

Authors:  Thomas E Ichim; Boris Minev; Todd Braciak; Brandon Luna; Ron Hunninghake; Nina A Mikirova; James A Jackson; Michael J Gonzalez; Jorge R Miranda-Massari; Doru T Alexandrescu; Constantin A Dasanu; Vladimir Bogin; Janis Ancans; R Brian Stevens; Boris Markosian; James Koropatnick; Chien-Shing Chen; Neil H Riordan
Journal:  J Transl Med       Date:  2011-03-04       Impact factor: 5.531

Review 7.  How to Optimize the Use of Blood Cultures for the Diagnosis of Bloodstream Infections? A State-of-the Art.

Authors:  Brigitte Lamy; Sylvie Dargère; Maiken C Arendrup; Jean-Jacques Parienti; Pierre Tattevin
Journal:  Front Microbiol       Date:  2016-05-12       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.